StonvexLoading…
StonvexStonvexStonvexCore line items from IIIV's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $110.19M | $52.67M | $213.16M | $158.26M |
Operating Income | $5.35M | $1.61M | $3.78M | $-4.81M |
Net Income | $1.95M | $484.00K | $17.87M | $12.88M |
EPS (Diluted) | $0.08 | $0.02 | $0.72 | $0.60 |
Total Assets | $636.42M | $595.93M | $638.41M | $623.27M |
Total Liabilities | $198.18M | $112.59M | $120.69M | $112.15M |
Cash & Equivalents | $7.14M | $37.52M | $66.67M | $55.54M |
Free Cash Flow OCF − CapEx | $23.43M | $13.81M | $3.75M | $-9.79M |
Shares Outstanding | 23.66M | 25.09M | 34.19M | 34.18M |